Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children

NCT01237041 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

37

Enrollment

NIH

Sponsor class

Stopped Study Medication unavailable

Conditions

Obesity
Short Stature
Growth Hormone Deficiency

Interventions

DRUG: Niacin First
DRUG: Placebo First
DRUG: Dose-Establishing Study 1 Niacin 250mg
DRUG: Dose-Establishing Study 1 Niacin 500mg
DRUG: Dose-Establishing Study 2 Niacin 500mg

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)